Edwards Lifesciences (EW) - News Mentions

Sign up to add (EW) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Boston Scientific
Boston Scientific
BSX		 1 0%
Intuitive Surgical
Intuitive Surgical
ISRG		 0 0%
Medtronic
Medtronic
MDT		 0 0%
Stryker
Stryker
SYK		 0 0%
Becton Dickinson and Co
Becton Dickinson and Co
BDX		 0 0%
Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback?
December 20
Is the Options Market Predicting a Spike in Edwards (EW) Stock?
December 19
Edwards Lifesciences Co. (NYSE:EW) Receives $78.65 Average Price Target from Analysts
December 18
Edwards Lifesciences (NYSE:EW) Stock Rating Upgraded by Bank of America
December 16
B of A Securities Upgrades Edwards Lifesciences (EW)
December 16
Edwards Lifesciences just upgraded at BofA, here's why
December 16
Zacks Research Brokers Raise Earnings Estimates for EW
December 15
Zacks Research Issues Positive Forecast for EW Earnings
December 14
EW DEADLINE TODAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important December 13 Deadline in Securities Class Action – EW
December 13
Edwards Lifesciences (NYSE:EW) Given New $83.00 Price Target at Citigroup
December 13
Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?
December 12
Edwards Lifesciences (EW) Investors Alerted to Today's Lead Plaintiff Deadline in Class Action Lawsuit Over TAVM Platform Disclosures - Hagens Berman
December 12
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW
December 12
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending – Hagens Berman
December 12
EW COURT DEADLINE TOMORROW: BFA Law Alerts Edwards Lifesciences Investors of Tomorrow’s December 13 Securities Fraud Class Action Deadline (NYSE:EW)
December 12
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - EW
December 12

Month over Month

Est. daily news mentions.

Nov 2024 1
Oct 2024 1
Sep 2024 0
Aug 2024 0
Jul 2024 1

How often is Edwards Lifesciences mentioned in the news?

Edwards Lifesciences was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Edwards Lifesciences performing compared to its industry peers?

Edwards Lifesciences underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Edwards Lifesciences in the last month?

There has been no significant change in the number of news mentions for Edwards Lifesciences' compared to the last month.

Why is it important to track news mentions for Edwards Lifesciences?

By monitoring mentions in the news for Edwards Lifesciences, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Edwards Lifesciences, ultimately improving their investment strategies.

Sign up and get more insights on Edwards Lifesciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact